menu
    • menu

    Company profile for Insulet Corporation

    NEW Drugs in Dev: 1
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, wit...
    Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Insulet CorporationUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    100 Nagog Park Acton, MA 01720
    Telephone
    Telephone
    (+1) 978-600-7000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.insulet.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Insulet Unveils Latest Enhancements to Omnipod Insulin System
    Insulet Unveils Latest Enhancements to Omnipod Insulin System

    05 Jun 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/medtech/insulet-debuts-latest-enhancement-its-popular-omnipod-insulin-delivery-system

    FIERCE BIOTECH
    05 Jun 2026
    Share Share
    Insulet Spotlights Omnipod Data on Simplifying Diabetes at ADA'26
    Insulet Spotlights Omnipod Data on Simplifying Diabetes at ADA'26

    04 Jun 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260604228498/en/Insulet-to-Spotlight-New-Data-and-Innovations-Demonstrating-How-Omnipod-Simplifies-Diabetes-Management-and-Delivers-Strong-Clinical-Outcomes-at-the-American-Diabetes-Association-86th-Scientific-Sessions

    BUSINESSWIRE
    04 Jun 2026
    Share Share
    Insulet Upgrades Omnipod 5 Algorithm, Adds FreeStyle Libre 3 Plus
    Insulet Upgrades Omnipod 5 Algorithm, Adds FreeStyle Libre 3 Plus

    03 Jun 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260603466418/en/Insulet-Announces-U.S.-Rollout-of-Enhanced-Omnipod-5-Algorithm-and-Expands-Compatibility-with-Abbotts-FreeStyle-Libre-3-Plus-Sensor

    BUSINESSWIRE
    03 Jun 2026
    Share Share
    Insulet to Present at William Blair Growth Stock Conference
    Insulet to Present at William Blair Growth Stock Conference

    27 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260527354082/en/Insulet-to-Participate-in-William-Blair-46th-Annual-Growth-Stock-Conference

    BUSINESSWIRE
    27 May 2026
    Share Share
    Insulet Reports First Quarter 2026 Results
    Insulet Reports First Quarter 2026 Results

    06 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-06/insulet-reports-first-quarter-2026-results

    PHARMIWEB
    06 May 2026
    Share Share
    Insulet Unveils 2025 Sustainability Report
    Insulet Unveils 2025 Sustainability Report

    05 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260505564581/en/Insulet-Unveils-2025-Sustainability-Report-Highlighting-Strong-Momentum-Across-Key-Priorities

    BUSINESSWIRE
    05 May 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search